Category Archives: Indian Patent Law

India will not respond under pressure on IPR issues

Source : The Hindu, 3 May, 2015 India will keep its ‘national interest’ in mind while framing its new intellectual property rights (IPR) policy and not work under pressure of any country, Commerce and Industry Minister Nirmala Sitharaman has said. … Continue reading

Posted in Indian Patent Law, Intellectual Property, TRIPS, TRIPS plus, Uncategorized, US pressure on India, USTR 301 report | Leave a comment

Intellectual property concerns: India still in US priority watch list

Source : Hindustan Times, 1 May, 2015 Based on positive developments in the past year, the US Trade Representative is keeping India on the priority watch list of countries with suspect intellectual property rights regimes. The USTR said in its … Continue reading

Posted in Indian Patent Law, Intellectual Property, TRIPS, TRIPS plus, US pressure on India, USTR 301 report | Leave a comment

A bitter pill for pharma units

Source: Hindu Business Line , 3 May 2015 The thriving Indian generic pharmaceutical industry has, over the past decade, earned its stripes globally as a source of reliable and cheap generic versions of exorbitantly priced medicines made by multi-national pharmaceutical companies. … Continue reading

Posted in data exclusivity, Indian Patent Law, Intellectual Property, US pressure on India, USTR 301 report | Leave a comment

DNP+ Press Release: Increasing IP barriers impact on generic medicines ‘Made in India’

Increasing IP barriers will have severe impact on generic medicines ‘Made in India’ Indian Prime Minister Must Resist Big Pharma Pressure to Trade Away Medicines New Delhi, 29 April 2015: At a conference titled  ‘IP as Frontline Tool for Make … Continue reading

Posted in access to medicines, Generic drug, Indian Patent Law, Intellectual Property, IPR policy, Make in India Campaign | Leave a comment

Letter from DNP+ to PM Modi on the adverse impact of IP on Affordable Generic Medicines ‘Made in India’

Dear Mrs. Sitharaman, Mr. Kant, Mr. Kher, Mr. Aggarwal, India’s role in ensuring global access to life-saving medicines is vital. India is often referred to as the ‘pharmacy of the developing world’ because of its critical role in providing affordable generic … Continue reading

Posted in Generic drug, Indian Patent Law, Make in India Campaign, patent, TRIPS, TRIPS plus | Leave a comment

PM Modi in favour of amending India’s Patent Law at par with global parameters

“If we do not follow global parameters on intellectual property rights, then the world will not establish relationship with us.” said PM Modi inaugurating Global Exhibition on services. Watch Modi’s speech (in Hindi) here (from 1:01mins-1:26mins)  

Posted in Indian Patent Law, IP Rights | Leave a comment

Need to bring our patent laws on par with global standards: Narendra Modi

Prime Minister Modi at the Global Exhibition on Services in New Delhi on Thursday. Photo: PTI Source: Livemint, 24 April 2015 New Delhi: India’s patent laws should be brought on par with global standards to make Asia’s third largest economy … Continue reading

Posted in Indian Patent Law, TRIPS, TRIPS plus | Tagged | Leave a comment